Introduction
Authors
Namrita Ashokprabhu1,2, Khaled Ziada, MD3, Edouard Daher, MD4, Leslie Cho, MD3, ChristianW. Schmidt, MS2, Yulith Roca, MD1,2, Cassady Palmer1,2, Sukhleen Kaur1,2,Timothy D. Henry,MD2,Carl J. Pepine, MD5, and Odayme Quesada, MD1,2,6
1Women’s Heart Center, The Christ Hospital Heart and Vascular Institute, Cincinnati, OH, USA; 2The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital, Cincinnati,OH, USA; 3Cleveland Clinic, Cleveland, OH; 4Ascension St.John, Detroit, MI; 5University of Florida, Gainesville, FL; 6Department of Internal Medicine, University of Cincinnati, Cincinnati, OH
Background
- Coronary microvascular dysfunction (CMD) is associated with a nearly 4-fold increase in mortality.
- Current diagnostic modalities for CMD are limited by access, cost, and exposure of ionizing radiation.
- Magnetocardiography (MCG) is a rest-based scan that measures weak magnetic fields generated by natural cardiac ionic currents.
Purpose
Investigate MCG’s ability to detect CMD in patients with ischemia and no obstructive coronary artery disease (ANOCA).